88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

Seaweed extract shown to relieve prostate symptoms In a breakthrough clinical trial undertaken by Australian biotechnology company Marinova, a unique seaweed extract has been shown to relieve the symptoms of benign prostatic hyperplasia (BPH). ... 2026-07-27T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical WALTHAM, Mass. , July 24, 2026 /PRNewswire/ -- Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Laminar Pharma Announces "Last Patient, Last Visit" in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients PALMA DE MALLORCA, Spain , July 24, 2026 /PRNewswire/ -- Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
ArkBio Completes all Cohort Dosing in Australian Phase I Trial with Influenza AFC Drug AK0406 SHANGHAI , July 24, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that all cohorts of healthy volunteers have been dosed in an Australian Phase I ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed Announces Positive Profit Alert for 2026 Interim Results, Marking Seventh Consecutive Profitable Half-Year as Platform-Based Advantages Drive Sustainable Growth CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 24, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company focused on the discovery ... 2026-07-24T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Fapon Showcases AI-Engineered Enzymes and Alzheimer's Solutions at ADLM 2026, Reinforcing North American Commitment ANAHEIM, Calif. , July 24, 2026 /PRNewswire/ -- Fapon, a trusted global IVD provider with deepening roots in North America, will exhibit at ADLM 2026 from July 26 to 30 in Anaheim, California. The company ... 2026-07-24T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
AH-008 Achieves Key Clinical Milestone with Successful First Subject First Dose (FSFD) in Phase I Study for Prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN) TAIPEI , July 23, 2026 /PRNewswire/ -- AnHorn Medicines today announced the successful completion of the first subject first dose in the Phase I clinical trial of AH-008, a first-in-class neuroprotective ... 2026-07-23T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NYSE Content Update: Fourth Annual AI x Bio Summit to Commence at the NYSE NYSE issues a pre-market daily advisory direct from the trading floor. ... 2026-07-23T Banking/Financial Service Biotechnology Computer/Electronics
PUBLIC TRUST IN HEALTH INNOVATION IS SHAPED MORE BY MINDSET THAN DEMOGRAPHICS, DNV RESEARCH FINDS OSLO, Norway , July 23, 2026 /PRNewswire/ -- Public trust in health innovation may be less predictable than healthcare organizations assume, according to new research from DNV, the independent assurance ... 2026-07-23T Biotechnology Health Care/Hospital Infectious Disease Control
Moa Technology raises Series C round co-led by Oxford Science Enterprises and Supernova Invest OXFORD, England , July 23, 2026 /PRNewswire/ -- Moa Technology ("Moa"), an agricultural biotechnology company focused on discovering novel mode of action herbicides, announces a £22.2 ... 2026-07-23T Agriculture Biotechnology Chemical Computer/Electronics

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved